Advanced search×

[Treatment of patients with complicated tonsillogenic infection].

E A EA Kirasirova, D G DG Gorban, N V NV Lafutkina, N N NN Tarasenkova, N A NA Miroshnichenko, and O K OK Piminidi

Vestn Otorinolaringol (2010) PMID 20517283

The number of patients with pyo-inflammatory complications associated with chronic tonsillitis has increased in the recent years. The objective of this paper was to analyse the frequency of stenotic conditions caused by purulent complications of tonsillogenic infection. An algorithm is proposed for diagnostic examination and treatment of patients with descending tonsillogenic infection suffering obstruction of the upper respiratory tract.

Version: za2963e q8za1 q8zbc q8zc3 q8zda q8ze3 q8zff q8zge

Similar articles you may find interesting…

  1. Heart or lung transplanted patients' retrospective views on information and support while waiting for transplantation
    Bodil Ivarsson, Björn Ekmehag, and Trygve Sjöberg

    J Clin Nurs 22(11-12):1620-1628 (2013) PMID 23039262

    Information and support in connection to heart or lung transplantation are a complex and multifaceted issue involving patient-related, family-related, disease-related and treatment-related factors as well as experiences related to the social situation, the healthcare system and society. Transplant p...
  2. Estimates of HCV-1 Patients Attaining RVR Following Dual Therapy with Peg-Interferon and Ribavirin
    A Andriulli, A Iacobellis, and G Niro

    Dig Dis Sci 58(5):1371-1382 (2013) PMID 23187978

    One fifth to one fourth of hepatitis C virus genotype 1 (HCV-1) patients can be safely treated with dual therapy of Peg-IFN/ribavirin, and may be spared from cost and inconvenience of regimens considering the addition of HCV protease inhibitors....
  3. The association between socioeconomic status and survival among children with Hodgkin and non-Hodgkin lymphomas in a universal health care s...
    Denise Darmawikarta, Jason D Pole, and Mark Greenberg

    Pediatr Blood Cancer 60(7):1171-1177 (2013) PMID 23129171

    A total of 692 patients were included in the analysis: 302 HL and 390 NHL. SES was not associated with survival (overall or event-free) among HL and NHL patients (P > 0.05 for all four comparisons, i.e., HL/NHL, EFS/OS) after adjustment for age, sex, period of diagnosis, and disease stage. There...